ouabain has been researched along with am 251 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alger, BE; Mason, SE; Reich, CG | 1 |
| Araya, KA; David Pessoa Mahana, C; González, LG | 1 |
2 other study(ies) available for ouabain and am 251
| Article | Year |
|---|---|
Novel form of LTD induced by transient, partial inhibition of the Na,K-pump in rat hippocampal CA1 cells.
Topics: Animals; Drug Interactions; Electric Stimulation; Electrophysiology; Enzyme Inhibitors; Evoked Potentials; Hippocampus; Imidazoles; In Vitro Techniques; Indoles; Long-Term Synaptic Depression; Male; Maleimides; Neural Inhibition; Neurons; Ouabain; Peptides; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Time Factors | 2004 |
Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC.
Topics: Animals; Benzoxazines; Brain; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Enzyme Inhibitors; Female; GTP-Binding Protein alpha Subunits, Gi-Go; In Vitro Techniques; Mice; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Ouabain; Pertussis Toxin; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Sodium-Potassium-Exchanging ATPase; Synaptosomes | 2007 |